Brief: Santhera Pharmaceuticals FY Net Loss At CHF -55.5 Mln

Santhera Pharmaceuticals Holding AG

10/06/2022 06:03

June 10 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
 SANN.S :
    * SANTHERA REPORTS 2021 ANNUAL RESULTS
    * FY NET REVENUE FROM CONTRACTS WITH CUSTOMERS OF CHF -1.6
MILLION
    * FY OPERATING EXPENSES OF CHF 51.9 MILLION, REDUCED BY 11%
    * FY NET RESULT OF CHF -55.5 MILLION (2020: CHF -67.7
MILLION)
    * FY CASH AND CASH EQUIVALENTS OF CHF 21.2 MILLION (DECEMBER
31,
2021)
    * FY OPERATING CASH FLOW CHF -37.4 MILLION
    * FY REVENUE FROM CONTRACTS WITH CUSTOMERS OF CHF -1.6
MILLION
(2020: CHF 15.0 MILLION)
    * FY OPERATING RESULT OF CHF -56.9MILLION (2020: CHF -53.1
MILLION) AND NET RESULT OF CHF -55.5 MILLION (2020: CHF -67.7
MILLION)

Source text for Eikon:  ID:nGNE8GSf9z 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))